Stock screenerAll disclosures →
EDGAR →
KURA
Conviction 50HealthcareScan · Mon, Aug 10, 2026KURA$9.87+3.13%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.35M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.87
Change+3.13%
Gap-0.31%
Rel volume3.63×
Avg volume1.27M
Avg $ vol12.7M
SMA 2010.03
SMA 5010.07
SMA 2009.63
Price vs 50-1.96%
Price vs 200+2.50%
MA stackmixed
50/200 cross—
Supertrenddown · 10.62
RSI (14)49
MACD hist-0.04
MACD cross—
Stoch %K / %D51 / 35
ADX (14)19
+DI / −DI20 / 23
RSI divergence—
MACD divergence—
ATR %+5.04%
ADR %4.84%
52w high12.14
52w low5.54
From 52w high-18.70%
Above 52w low+78.16%
New 52w highNo
SqueezeOff
Bollinger width31.05%
%B0.45
Donchian pos39.18%
Donchian high11.50
Donchian low8.82
AVWAP (52w high)9.68
vs AVWAP high+2.00%
AVWAP (52w low)9.45
vs AVWAP low+4.47%
OBV trendFlat
Chaikin MF (20)0.08
Today vs 20d3.63×
Avg vol (14d)1.35M
Avg vol (20d)1.27M
Avg $ vol (20d)12.7M
Market cap876.2M
RS 3m (vs SPY)-3.01%
RS 6m (vs SPY)+15.21%
RS line new highNo
Trend template4/8
Technical rank51.5
1 week+7.40%
1 month-13.80%
3 months+4.78%
6 months+26.05%
1 year+65.60%
YTD-4.50%
P/E-3.14
P/B8.12
P/S12.98
P/FCF-12.39
EPS-3.18
Div yield—
ROE-258.30%
ROA-42.70%
Debt/Eq0.09
Current6.15
EV/EBITDA—
Gross margin—
Net margin-412.95%
Rev growth25.24%
EPS growth-60.17%
Price target28.11
Target upside184.80%
Analyst ratingBuy
Institutional104.76%
Ent. value846.87M
Revenue18.27M
Net income-73.33M
Gross profit—
Free cash flow-70.7M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out88.77M
Employees260
ListedTue, Aug 25, 2015
Free float78.06M
Float %87.9%
Short interest13.73M
Days to cover7.7d
Short volume61.5%
Squeeze score89 / 100
Next earningsWed, Aug 12, 2026 · after (2d)
EPS forecast−$0.89 · 4 est
Last EPS vs est−$0.83 vs −$0.88
Last surprise+5.7% beat
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank51.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.71
Support8.82
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KURA
No recent disclosed trades by Congress in KURA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KURA · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Leoni Mollie Chief Medical Officer · Common Stock · 2026-06-18 | Sell | 84.93K | $834K | 2026-06-18 | 2026-06-22 |
Hasnain Faheem Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
VASCONCELLES MICHAEL Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
Szela Mary T Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
Malley Thomas Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
SCHAFER CAROL Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
Collins Helen Louise Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
Parks Diane L. Director · Option to purchase common stock · 2026-06-04 | Grant | 35K | $0 | 2026-06-04 | 2026-06-04 |
Powl Brian T. Chief Commercial Officer · Common Stock · 2026-05-21 | Sell | 10K | $110K | 2026-05-21 | 2026-05-22 |
Powl Brian T. Chief Commercial Officer · Common Stock · 2026-05-19 | Sell | 339 | $3K | 2026-05-19 | 2026-05-20 |
SEC filings
EDGAR filings in KURA · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.